Netherlands· NL-6f560d645c97
Ofloxacine Unit Dose Medcor, 1,5 mg/0,5 ml oordruppels, oplossing
A ofloxacin product containing ofloxacine, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 3 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ofloxacin is registered in 3 of 19 countries.
Countries holding a registration under ATC S02AA16 (ofloxacin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 1 of them publish a price we can compare per daily dose
Ofloxacin · ATC S02AA16
3 / 19 countries
- Netherlands
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- OFLOXACINE
- Manufacturer
- Medcor Pharmaceuticals B.V.
- Country
- Netherlands (NL)
- ATC code
- S02AA16
- ATC class
- Ofloxacin
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id134497//113973
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ofloxacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesOfloxacinPreferred Pharmaceuticals Inc.
- United KingdomExocin 0.3% eye dropsMawdsley-Brooks & Company Ltd
- PolandFloxalDelfarma Sp. z o.o.
- GermanyFloxalDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
- FranceEXOCINE 0,3 POUR CENT, collyreABBVIE
- BelgiumOfloxacin-Pos 3 mg/mlURSAPHARM Benelux
- Japanオフロキサシン参天製薬
- SpainEXOCIN 3 MG/ML COLIRIO EN SOLUCIONAbbvie Spain, S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Floxal, Floxal Edo
- Belgium · Trafloxal, Trafloxal Edo
- Bulgaria · Медофлоксин, Офлоксацин Дра
- Cyprus · Cilox, Medofloxine
- Czechia · Floxal, Ofloxacin Unimed Pharma
- Germany · Floxal, Floxal Edo
- Estonia · Medofloxine, Ofloxin
- Spain · Exocin, Oflovir
- Finland · Exocin
- France · Exocine, Monoflocet
- United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
- Greece · Exocin, Oxatrex
- Croatia · Uniflox
- Hungary · Floxal, Grenis-Oflo
- Ireland · Exocin
- Italy · Dunaflot, Exocin
- Lithuania · Ofloxin, Uniflox
- Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
- Latvia · Ofloxin, Uniflox
- Malta · Uniflox Unimed Pharma
- Poland · Floxal, Oflodinex
- Portugal · Audret, Bioquil
- Romania · Floxal, Ofloxacină Laropharm
- Sweden · Ofloxacin Mibe
- Slovakia · Medofloxine, Ofloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f494825e-2c2a-4033-95da-fb5eba4580f1 GET /v1/drugs/f494825e-2c2a-4033-95da-fb5eba4580f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oordruppels, oplossing",
"route": "Auriculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h113973_smpc.pdf",
"strength": null,
"atc_label": "Ofloxacin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134497",
"excipients": [
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"WATER, GEZUIVERD",
"ZOUTZUUR (E 507)"
],
"substances": [
"OFLOXACINE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134497.pdf",
"authorised_at": "2025/09/11",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "134497//113973",
"additional_monitoring": "N"
}See everything about ofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.